Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AnaConDa-therapy in COVID-19 Patients

NCT05586126 is registered in ClinicalTrials.gov with Jeroen Bosch Ziekenhuis as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05586126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AnaConDa-therapy in COVID-19 Patients
Lead sponsor
Jeroen Bosch Ziekenhuis
Phase
Observational
Overall status
Terminated
Start date
October 1, 2020
Completion date
July 1, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars cov-2